 | • レポートコード：MRC2-11QY13563 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は急性虚血性脳卒中治療薬のグローバル市場について調査・分析したレポートです。種類別（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別急性虚血性脳卒中治療薬の競争状況、市場シェア ・世界の急性虚血性脳卒中治療薬市場：種類別市場規模 2015年-2020年（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤） ・世界の急性虚血性脳卒中治療薬市場：種類別市場規模予測 2021年-2026年（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤） ・世界の急性虚血性脳卒中治療薬市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界の急性虚血性脳卒中治療薬市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米の急性虚血性脳卒中治療薬市場分析：米国、カナダ ・ヨーロッパの急性虚血性脳卒中治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの急性虚血性脳卒中治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の急性虚血性脳卒中治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの急性虚血性脳卒中治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Boehringer Ingelheim、Roche、Sanofi、Biogen、Daiichi Sankyo、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
Technavio’s analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.
Market Analysis and Insights: Global Acute Ischemic Stroke Therapeutics Market
The global Acute Ischemic Stroke Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of 2.1%% during 2021-2026.
Global Acute Ischemic Stroke Therapeutics Scope and Market Size
Acute Ischemic Stroke Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Ischemic Stroke Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer
…
Market segment by Type, the product can be split into
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants
Market segment by Application, split into
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Ischemic Stroke Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Thrombolytic Therapeutics
1.4.3 Antihypertensive Therapeutics
1.4.4 Antiplatelet Therapeutics
1.4.5 Anticoagulants
1.5 Market by Application
1.5.1 Global Acute Ischemic Stroke Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Therapeutics Market Perspective (2015-2026)
2.2 Global Acute Ischemic Stroke Therapeutics Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Ischemic Stroke Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Acute Ischemic Stroke Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acute Ischemic Stroke Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Ischemic Stroke Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Therapeutics Players by Market Size
3.1.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Ischemic Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio
3.2.1 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Therapeutics Revenue in 2019
3.3 Acute Ischemic Stroke Therapeutics Key Players Head office and Area Served
3.4 Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
3.5 Date of Enter into Acute Ischemic Stroke Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
5.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
6.2 Acute Ischemic Stroke Therapeutics Key Players in North America (2019-2020)
6.3 North America Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
6.4 North America Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
7.2 Acute Ischemic Stroke Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
7.4 Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
8.2 Acute Ischemic Stroke Therapeutics Key Players in China (2019-2020)
8.3 China Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
8.4 China Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
9.2 Acute Ischemic Stroke Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
9.4 Japan Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
10.2 Acute Ischemic Stroke Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
11.2 Acute Ischemic Stroke Therapeutics Key Players in India (2019-2020)
11.3 India Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
11.4 India Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acute Ischemic Stroke Therapeutics Market Size (2015-2020)
12.2 Acute Ischemic Stroke Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Acute Ischemic Stroke Therapeutics Introduction
13.1.4 Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Introduction
13.2.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Acute Ischemic Stroke Therapeutics Introduction
13.3.4 Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Acute Ischemic Stroke Therapeutics Introduction
13.4.4 Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Biogen
13.5.1 Biogen Company Details
13.5.2 Biogen Business Overview
13.5.3 Biogen Acute Ischemic Stroke Therapeutics Introduction
13.5.4 Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020)
13.5.5 Biogen Recent Development
13.6 Daiichi Sankyo
13.6.1 Daiichi Sankyo Company Details
13.6.2 Daiichi Sankyo Business Overview
13.6.3 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Introduction
13.6.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020)
13.6.5 Daiichi Sankyo Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Acute Ischemic Stroke Therapeutics Introduction
13.7.4 Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acute Ischemic Stroke Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Ischemic Stroke Therapeutics Revenue
Table 3. Ranking of Global Top Acute Ischemic Stroke Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Thrombolytic Therapeutics
Table 6. Key Players of Antihypertensive Therapeutics
Table 7. Key Players of Antiplatelet Therapeutics
Table 8. Key Players of Anticoagulants
Table 9. Global Acute Ischemic Stroke Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Acute Ischemic Stroke Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Acute Ischemic Stroke Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Acute Ischemic Stroke Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Acute Ischemic Stroke Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Acute Ischemic Stroke Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Acute Ischemic Stroke Therapeutics Players
Table 20. Global Acute Ischemic Stroke Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Acute Ischemic Stroke Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Acute Ischemic Stroke Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Therapeutics as of 2019)
Table 23. Global Acute Ischemic Stroke Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
Table 26. Date of Enter into Acute Ischemic Stroke Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Acute Ischemic Stroke Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Acute Ischemic Stroke Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Acute Ischemic Stroke Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 36. North America Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 38. North America Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 42. Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 48. China Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 50. China Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 54. Japan Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 66. India Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 68. India Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Acute Ischemic Stroke Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Acute Ischemic Stroke Therapeutics Market Share (2019-2020)
Table 72. Central & South America Acute Ischemic Stroke Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Acute Ischemic Stroke Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Acute Ischemic Stroke Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Acute Ischemic Stroke Therapeutics Market Share by Application (2015-2020)
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Product
Table 79. Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 80. Bayer Recent Development
Table 81. Boehringer Ingelheim Company Details
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Product
Table 84. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 85. Boehringer Ingelheim Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Product
Table 89. Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 90. Roche Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Product
Table 94. Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 95. Sanofi Recent Development
Table 96. Biogen Company Details
Table 97. Biogen Business Overview
Table 98. Biogen Product
Table 99. Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 100. Biogen Recent Development
Table 101. Daiichi Sankyo Company Details
Table 102. Daiichi Sankyo Business Overview
Table 103. Daiichi Sankyo Product
Table 104. Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 105. Daiichi Sankyo Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Product
Table 109. Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2015-2020) (Million US$)
Table 110. Pfizer Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Ischemic Stroke Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Thrombolytic Therapeutics Features
Figure 3. Antihypertensive Therapeutics Features
Figure 4. Antiplatelet Therapeutics Features
Figure 5. Anticoagulants Features
Figure 6. Global Acute Ischemic Stroke Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Center Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Acute Ischemic Stroke Therapeutics Report Years Considered
Figure 11. Global Acute Ischemic Stroke Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Acute Ischemic Stroke Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Acute Ischemic Stroke Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Acute Ischemic Stroke Therapeutics Market Share by Players in 2019
Figure 16. Global Top Acute Ischemic Stroke Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Therapeutics Revenue in 2019
Figure 18. North America Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
虚血性脳卒中予防治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ischemic Cerebral Stroke Prevention Therapeutics Market The global Ischemic Cerebral Stroke Prevention Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ischemic Cerebral…- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 脳卒中診断・治療の世界市場（～2026年） Stroke refers to the brain attack. Stroke occurs when the supply of blood to the brain is either interrupted or reduced. Increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed …
- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 急性心不全（AHF）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 336 million by 2026, from US$ 262.2 million in 2020, at a CAGR of 26.8%% during 2021-2026. Global Acute Heart Failure (AHF) Thera…